Year |
Citation |
Score |
2010 |
Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, et al. Analysis of HIV tropism in Ugandan infants. Current Hiv Research. 8: 498-503. PMID 21073438 DOI: 10.2174/157016210793499187 |
0.73 |
|
2010 |
Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH. Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. Plos One. 5: e13259. PMID 20949006 DOI: 10.1371/Journal.Pone.0013259 |
0.745 |
|
2010 |
Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH. Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. Aids Research and Human Retroviruses. 26: 563-8. PMID 20455758 DOI: 10.1089/Aid.2009.0164 |
0.65 |
|
2009 |
Church JD, Huang W, Parkin N, Marlowe N, Guay LA, Omer SB, Musoke P, Jackson JB, Eshleman SH. Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. Aids Research and Human Retroviruses. 25: 657-63. PMID 19621988 DOI: 10.1089/Aid.2008.0235 |
0.803 |
|
2009 |
Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, et al. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. Aids Research and Human Retroviruses. 25: 673-7. PMID 19552593 DOI: 10.1089/Aid.2009.0003 |
0.729 |
|
2009 |
Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B, Eshleman SH. Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. Aids Research and Human Retroviruses. 25: 701-5. PMID 19552592 DOI: 10.1089/Aid.2009.0014 |
0.754 |
|
2009 |
Church JD, Eshleman SH. Reply to Krivine et al. Journal of Infectious Diseases. 199: 1554-1555. DOI: 10.1086/598480 |
0.435 |
|
2008 |
Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH. Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). Aids Research and Human Retroviruses. 24: 1209-13. PMID 18788912 DOI: 10.1089/Aid.2008.0109 |
0.769 |
|
2008 |
Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. The Journal of Infectious Diseases. 198: 1075-82. PMID 18684096 DOI: 10.1086/591503 |
0.753 |
|
2008 |
Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. The Journal of Infectious Diseases. 198: 465-9. PMID 18582198 DOI: 10.1086/590160 |
0.756 |
|
2008 |
Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH. HIV-1 tropism and survival in vertically infected Ugandan infants. The Journal of Infectious Diseases. 197: 1382-8. PMID 18444795 DOI: 10.1086/587492 |
0.719 |
|
2008 |
Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH. Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. Aids Research and Human Retroviruses. 24: 595-605. PMID 18370589 DOI: 10.1089/Aid.2007.0224 |
0.713 |
|
2007 |
Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH. HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. Aids Research and Human Retroviruses. 23: 764-8. PMID 17604538 DOI: 10.1089/Aid.2006.0272 |
0.763 |
|
2006 |
Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. The Journal of Molecular Diagnostics : Jmd. 8: 430-2; quiz 527. PMID 16931582 DOI: 10.2353/Jmoldx.2006.050148 |
0.751 |
|
2006 |
Eshleman SH, Church JD, Chen S, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Hoover DR. Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 518-21. PMID 16810119 DOI: 10.1097/01.Qai.0000221676.22069.B8 |
0.741 |
|
2006 |
Flys TS, Chen S, Jones DC, Hoover DR, Church JD, Fiscus SA, Mwatha A, Guay LA, Mmiro F, Musoke P, Kumwenda N, Taha TE, Jackson JB, Eshleman SH. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 610-3. PMID 16773030 DOI: 10.1097/01.Qai.0000221686.67810.20 |
0.765 |
|
Show low-probability matches. |